Applied Biosciences Corp. (APPB)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -749.71 Thousand | -1.24 Million | -905.05 Thousand | -673.46 Thousand | -150.83 Thousand | -30.25 Thousand |
| Net Income | -767.22 Thousand | -4.67 Million | -2.67 Million | -2.38 Million | -515.92 Thousand | -28.44 Thousand |
| Depreciation & Amortization | 174.49 Thousand | 204.04 Thousand | 40.62 Thousand | 224.77 Thousand | 19.95 Thousand | - |
| Deferred income taxes | - | - | -429.75 Thousand | - | - | - |
| Stock-based compensation | - | - | 1.05 Million | 607.78 | - | - |
| Change in working capital | -447.51 Thousand | 929.2 Thousand | 257.27 Thousand | -12.81 Thousand | -31.23 Thousand | -1806.00 |
| Other non-cash items | 290.52 Thousand | 2.29 Million | 847.07 Thousand | 1.5 Million | 376.36 Thousand | 27.12 |
| Investing Cash Flow | - | -1273.00 | -713.29 Thousand | -173.23 Thousand | -775 Thousand | - |
| Investments in PPE | 4.00 | -1274.00 | -1555.00 | -4699.00 | -150 Thousand | - |
| Acquisitions | - | - | -711.73 Thousand | - | -325 Thousand | - |
| Investment purchases | - | - | - | -168.53 Thousand | -300 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | 150 Thousand | - |
| Other Investing Activities | - | - | - | -168.54 | -450.00 | - |
| Financing Cash Flow | 225 Thousand | 1.72 Million | 1.6 Million | 695 Thousand | 1.13 Million | 32.44 Thousand |
| Debt repayment | -225 Thousand | -1.72 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -100 Thousand | - | - |
| Common Stock Issuance | - | - | 75 Thousand | 795 Thousand | 1.12 Million | 3090.00 |
| Other Financing Activities | - | - | 1.52 Million | 795.00 | 13.37 Thousand | 29.35 Thousand |
| Accounts receivables | 11.11 Thousand | 70.91 Thousand | -23.02 Thousand | -6709.00 | -5677.00 | - |
| Accounts payables | -584.65 Thousand | 902.36 Thousand | - | 4301.00 | - | -1806.00 |
| Inventory | 127.75 Thousand | -49.01 Thousand | -49.66 Thousand | -6375.00 | -16.83 Thousand | - |
| Other working capital | -1724.00 | 4948.00 | 329.95 Thousand | -4035.00 | -8726.00 | - |
| Cash at beginning of period | 525.06 Thousand | 47.04 Thousand | 60.93 Thousand | 212.63 Thousand | - | - |
| Cash at end of period | 350.00 | 525.06 Thousand | 47.04 Thousand | 60.93 Thousand | 212.63 Thousand | 2191.00 |
| Capital Expenditure | 4.00 | -1274.00 | -1555.00 | -4699.00 | -150 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -524.71 Thousand | 478.02 Thousand | -13.89 Thousand | -151.7 Thousand | 212.63 Thousand | 2191.00 |
| Free Cash Flow | -749.71 Thousand | -1.24 Million | -906.6 Thousand | -678.16 Thousand | -300.83 Thousand | -30.25 Thousand |
| Breakdown | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 FY | 2019 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.42 Million | -855.23 Thousand | -507.92 Thousand | -271.96 Thousand | -2.67 Million | -1.89 Million |
| Depreciation & Amortization | 62.96 Thousand | 39.74 Thousand | 39.74 Thousand | 39.74 Thousand | 40.62 Thousand | 292.00 |
| Deferred income taxes | 368.31 Thousand | - | - | - | -429.75 Thousand | - |
| Stock-based compensation | 81 Thousand | 70.00 | - | -76.41 | 1.05 Million | 1150.20 |
| Change in working capital | 489.78 Thousand | 347.51 Thousand | 22.18 Thousand | 78.54 Thousand | 257.27 Thousand | -149.39 Thousand |
| Other non-cash items | 371.65 Thousand | 101.43 Thousand | 46.95 Thousand | 37.47 Thousand | 847.07 Thousand | 1.54 Million |
| Investing Cash Flow | - | - | - | -163.29 Thousand | -713.29 Thousand | -550 Thousand |
| Investments in PPE | - | - | - | -1555.00 | -1555.00 | - |
| Acquisitions | - | - | - | -161.73 Thousand | -711.73 Thousand | -550 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | 402 Thousand | 389.93 Thousand | 84.95 Thousand | 1.6 Million | 1.28 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 75 Thousand | - |
| Other Financing Activities | - | 402.00 | 389.94 | 84.96 | 1.52 Million | 1280.00 |
| Accounts receivables | -12.08 Thousand | -10.59 Thousand | 76.42 Thousand | -17.58 Thousand | -23.02 Thousand | -6757.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 4142.00 | 9689.00 | -36.61 Thousand | -8632.00 | -49.66 Thousand | -18.43 Thousand |
| Other working capital | 497.72 Thousand | 348.41 Thousand | -17.62 Thousand | 104.76 Thousand | 329.95 Thousand | -124.2 Thousand |
| Cash at beginning of period | 73.41 Thousand | 37.94 Thousand | 47.04 Thousand | 241.57 Thousand | 60.93 Thousand | 6924.00 |
| Cash at end of period | 21.26 Thousand | 73.41 Thousand | 37.94 Thousand | 47.04 Thousand | 47.04 Thousand | 241.57 Thousand |
| Capital Expenditure | - | - | - | -1555.00 | -1555.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -52.14 Thousand | 35.47 Thousand | -9104.00 | -194.52 Thousand | -13.89 Thousand | 234.64 Thousand |
| Free Cash Flow | -52.14 Thousand | -366.52 Thousand | -399.04 Thousand | -117.74 Thousand | -906.6 Thousand | -495.35 Thousand |
HAVELLS
OAL
HEWA
EPR-PG
STM
SMI